Molecular profiling to identify molecular mechanism in esophageal cancer with familial clustering

Oncology Reports

Volumn 21, Issue 5, 2009, Pages 1135-1146

  Chattopadhyay, Indranil ^a   Phukan, Rupkumar ^c   Singh, Avninder ^a   Vasudevan, Madavan ^d   Purkayastha, Joydeep ^b   Hewitt, Stephen ^e   Kataki, Amal ^b   Mahanta, Jagadish ^c   Kapur, Sujala ^a   Saxena, Sunita ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

^b DR B BOROOAH CANCER INSTITUTE   (India)

^c Regional Medical Research Center   (India)

^d Genotypic Technology Private Limited   (India)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Expression profile; Familial esophageal cancer; Microarray

Indexed keywords

ARGINASE; B LYMPHOCYTE RECEPTOR; CALCIUM; CD14 ANTIGEN; CELL NUCLEUS RECEPTOR; COLECALCIFEROL RECEPTOR; COLLAGEN TYPE 14; COLLAGEN TYPE 4; COMPLEMENTARY DNA; CYTOKERATIN 4; EPOXIDE HYDROLASE; GLUTAMATE RECEPTOR 3; INSULIN; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 1; LYMPHOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN 9; MEMBRANE PROTEIN; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; OCTAMER TRANSCRIPTION FACTOR 2; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 4; PROTEIN SHC; SMAD1 PROTEIN; THROMBOCYTE FACTOR 4; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1;

ADULT; AGED; ARTICLE; CALCIUM SIGNALING; CANCER RADIOTHERAPY; CARCINOGENESIS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENDOSCOPIC BIOPSY; ENVIRONMENTAL FACTOR; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; EXTRACELLULAR MATRIX; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UPREGULATION; XENOBIOTIC METABOLISM;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FAMILY HEALTH; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 67649370974     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000333     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Stoner GD and Gupta A: Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 22: 1737-1746, 2001.
3. Su H, Hu N, Shih J, Hu Y, Wang QH, Chuang EY, Roth MJ, Wang C, Goldstein AM, Ding T, Dawsey SM, Giffen C, Emmert-Buck MR and Taylor PR: Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 63: 3872-3876, 2003.
4. Nyren O and Adami H-O: Esophageal Cancer. In: Text Book of Cancer Epidemiology, H-O Adami, D Hunter, D Trichopoulos (eds). Oxford University Press, pp137-155, 2002.
5. Phukan RK, Mahanta J and Hazarika NC: Annual Report, Regional Medical Research Center, Dibrugarh, Assam, India. pp21-24: 2005-2006.
6. Chattopadhyay I, Kapur S, Purkayastha J, Phukan R, Kataki A, Mahanta J and Saxena S: Gene expression profile of esophageal cancer in North East India by cDNA microarray analysis. World J Gastroenterol 13: 1438-1444, 2007.
7. Hemminki K and Li X: Familial risks of cancer as a guide to gene identification and mode of inheritance. Int J Cancer 110: 291-294, 2004.
8. Xue LY, Hu N, Song YM, Zou SM, Shou JZ, Qian LX, Ren LQ, Lin DM, Tong T, He ZG, Zhan QM, Taylor PR and Lu N: Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. BMC Cancer: 6296, 2006.
9. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
10. Perwez HS and Curtis CH: Inflammation and cancer: An ancient link with novel potentials. Int J Cancer 121: 2373-2380, 2007.
11. Federico A, Morgillo F, Tuccillo C, Ciardiello F and Loguercio C: Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121: 2381-2386, 2007.
12. Ikeda K, Iyama K, Ishikawa N, Egami H, Nakao M, Sado Y, Ninomiya Y and Baba H: Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region. Am J Pathol 168: 856-865, 2006.
13. Yamaguchi K, Ogawa K, Katsube T, Shimao K, Konno S, Shimakawa T, Yoshimatsu K, Naritaka Y, Yagawa H and Hirose K: Platelet factor 4-gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis. Anticancer Res 25: 847-851, 2005.
14. Sulpice E, Contreres JO, Lacour J, Bryckaert M and Tobelem G: Platelet factor 4 disrupts the intracellular signalling cascade induced by vascular endothelial growth factor by both KDR dependent and independent mechanisms. Eur J Biochem 271: 3310-3318, 2004.
15. Sohn SJ, Sarvis BK, Cado D and Winoto A: ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression. J Biol Chem 277: 43344-43351, 2002.
16. Kiyohara C, Yoshimasu K, Takayama K and Nakanishi Y: EPHX1 polymorphisms and the risk of lung cancer: a HuGE review. Epidemiology 17: 89-99, 2006.
17. Shoshan-Barmatz V, Israelson A, Brdiczka D and Sheu SS: The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death. Curr Pharm Des 12: 2249-2270, 2006.
18. Qiu T, Grizzle WE, Oelschlager DK, Shen X and Cao X: Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1. EMBO J 26: 346-357, 2007.
19. Huang B, Zhao J, Unkeless JC, Feng ZH and Xiong H: TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27: 218-224, 2008.
20. Bourguignon LY, Peyrollier K, Gilad E and Brightman A: Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. J Biol Chem 282: 1265-1280, 2007.
21. Yang Y, Lee JH and Kim KY: The interferon-inducible 9-27 gene modulates the susceptibility to natural killer cells and the invasiveness of gastric cancer cells. Cancer Lett 221: 191-200, 2005.
22. Rodriguez PC, Hernandez CP and Quiceno D: Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med 202: 931-939, 2005.
23. Mielczarek M, Chrzanowska A, Scibior D, Skwarek A, Ashamiss F, Lewandowska K and Baranczyk-Kuzma A: Arginase as a useful factor for the diagnosis of colorectal cancer liver metastases. Int J Biol Markers 21: 40-44, 2006.
24. Nabarro S, Himoudi N and Papanastasiou A: Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein. J Exp Med 202: 1399-1410, 2005.
25. Kim JH, Kim MK and Lee HE: Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer. Mod Pathol 20: 835-842, 2007.
26. Gascoyne DM, Kypta RM and Vivanco MM: Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL. J Biol Chem 278: 18022-18029, 2003.
27. Runnebaum IB and Bruning A: Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2. Clin Cancer Res 11: 6325-6332, 2005.
28. Park SY, Lee SA and Han IH: Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma. Oncol Rep 17: 81-87, 2007.